We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
HPLC‐QTOF/MS‐based metabolomics to explore the molecular mechanisms of Yiqi Fumai Lyophilized Injection in heart failure mice.
- Authors
Yuan, Guang‐ying; Liu, Ze‐liang; Lai, Qiong; Fu, Fei; Zhang, Lu; Kou, Jun‐ping; Yu, Bo‐yang; Li, Fang
- Abstract
Chronic heart failure is a common and fatal disease triggered by loss of normal cardiac function. Yiqi Fumai Lyophilized Injection is widely used in the treatment of cardiovascular diseases, especially chronic heart failure. In this study, a model of chronic heart failure in mice was established with permanent coronary artery ligation followed by Yiqi Fumai Lyophilized Injection intervention for 14 days. Then, the endogenous metabolites of mice plasma and urine samples were screened through nontargeted metabolomics techniques. The results indicated that Yiqi Fumai Lyophilized Injection treatment changed the metabolic pattern of chronic heart failure and regulated valine, leucine, and isoleucine biosynthesis, taurine and hypotaurine metabolism, histidine metabolism and arginine biosynthesis, etc. Finally, the cardioprotective mechanism of Yiqi Fumai Lyophilized Injection was further verified in the mouse model of chronic heart failure and angiotensin II‐induced cardiac fibroblasts based on metabolomics. The results showed that Yiqi Fumai Lyophilized Injection could inhibit myocardial fibrosis to improve chronic heart failure. This study firstly elucidated the metabolic network and pathways regulated by Yiqi Fumai Lyophilized Injection, which might facilitate the realization of the clinically accurate application of Yiqi Fumai Lyophilized Injection in the treatment of chronic heart failure.
- Subjects
HEART failure; ANGIOTENSIN II; METABOLOMICS; LABORATORY mice; THERAPEUTICS
- Publication
Journal of Separation Science, 2021, Vol 44, Issue 13, p2545
- ISSN
1615-9306
- Publication type
Article
- DOI
10.1002/jssc.202001269